The effects of vitamin D therapy on outcomes for hispanic patients hospitalized for COVID-19
et al., Abstracts from the 2022 Annual Meeting of the Society of General Internal Medicine, Journal of General Internal Medicine, doi:10.1007/s11606-022-07653-8
Shahid et al.
, The effects of vitamin D therapy on outcomes for hispanic patients hospitalized for COVID-19
, Abstracts from the 2022 Annual Meeting of the Society of General Internal Medicine, Journal of General Internal Medicine, doi:10.1007/s11606-022-07653-8
risk of death, 38.0% lower, RR 0.62, p < 0.001, treatment 705, control 773.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Shahid et al., 17 Jun 2022, retrospective, USA, peer-reviewed, 2 authors, dosage not specified.
Abstract: Abstracts from the 2022 Annual Meeting of the Society of
General Internal Medicine
J Gen Intern Med 37(Suppl 2):S129–S664
© The Author(s), under exclusive licence to Society of General Internal
THE EFFECTS OF VITAMIN D THERAPY ON OUTCOMES FOR
HISPANIC PATIENTS HOSPITALIZED FOR COVID-19
Saqib Shahid1; Fatma Dihowm2
Department of Internal Medicine, Texas Tech University Health Sciences
Center El Paso, El Paso, TX
Internal Medicine, Texas Tech University Health Science Center, El paso,
TX. (Control ID #3709726)
BACKGROUND: The SARS-CoV-2 novel coronavirus that causes COVID19 has been shown to more severely affect individuals with underlying
conditions, such as metabolic syndrome or diabetes. This is a reason why
SARS-CoV-2 more severely affects populations at risk for these conditions,
notably the Hispanic population. Vitamin D has been shown to be a positive
immunomodulatory actor, shown to upregulate production of CAMP
(cathelicidin antimicrobial peptide) and its effect on mitigating the severity of
respiratory illnesses has been widely studied. Additionally, given vitamin D’s
role in the functional regulation of pancreatic beta cells, this study aims to
determine whether vitamin D plays a significant role in providing better
outcomes for Hispanic patients with diabetes. Data will be gathered for patients
treated at University Medical Center in El Paso, where the majority of the
population treated is Hispanic, allowing us the opportunity to observe phenomena unique to this population.
METHODS: We collected data from the charts of 1,478 Hispanic patients
who were hospitalized for COVID-19 at University Medical Center El Paso.
Comparisons were made between patients who received VItamin D therapy
(705) and those who did not (773). The main outcome that was assessed was
mortality, as well as secondary outcomes such as length of hospital stay, need
for supplemental oxygen upon discharge, and ICU admission. Further
comparisons were made between patients who suffer from diabetes and those
who do not.
RESULTS: Our preliminary results by way of a univariate analysis show that
patients who were given Vitamin D therapy during their hospitalization had
significantly lower rates of mortality (p<0.001). Patients in the group that
received Vitamin D therapy were 38% less likely to die during their hospital
stay (p<0.001). We also discovered that patients admitted to UMC El Paso
were significantly more likely to be given Vitamin D therapy if they presented
with respiratory and GI symptoms (p<0.001). A multivariate analysis on the
relationship between previous history of diabetes and the efficacy of Vitamin D
therapy is pending.
CONCLUSIONS: Our results show that Vitamin D therapy as a part of the
treatment protocol for COVID-19 can significantly reduce mortality during
hospitalization. As a result of the unique composition of our patient population,
these findings can help build standards of practice that are applicable to the
specific needs of Hispanic patients throughout the course of the pandemic.
Because patients in the Hispanic population are more susceptible to severe
symptoms due to their predisposition to comorbid conditions like diabetes,
using protocols informed by evidence has the potential to prevent mortality on
a large scale.
is less effective
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation. FLCCC
provide treatment protocols.